Amyloid-β modulates the phase separation and aggregation of α-synuclein

Alexander Röntgen, Zenon Toprakcioglu, Owen M. Morris, Michele VendruscoloProceedings of the National Academy of Sciences 2025 · DOI

TL;DR

This study reveals that amyloid-beta (Aβ) peptides, specifically Aβ42 and Aβ40, influence the phase separation and aggregation of α-synuclein (αSyn) through distinct mechanisms. Aβ42 acts as a nucleation site for αSyn condensation, while Aβ40 integrates into αSyn condensates and accelerates their aggregation, offering crucial insights into the complex interplay of these proteins in neurodegenerative diseases.

What Problem Does This Paper Address?

Alzheimer's and Parkinson's diseases, two devastating neurodegenerative disorders, are characterized by the accumulation of misfolded protein aggregates: amyloid-beta (Aβ) in Alzheimer's and α-synuclein (αSyn) in Parkinson's. Increasingly, evidence suggests these proteins don't act in isolation but rather co-aggregate, hinting at a synergistic relationship that might drive disease progression. However, the precise molecular mechanisms governing this co-aggregation and how Aβ influences αSyn's behavior, particularly its tendency to form liquid-like condensates before solidifying into amyloid fibrils, remained largely unclear. This paper aims to unravel these complex interactions by investigating how different Aβ variants modulate αSyn's phase separation and aggregation dynamics.

Methods

The researchers employed a multi-pronged approach combining biophysical techniques, chemical kinetics, and fluorescence microscopy.

  • Confocal Microscopy: This was the primary tool for visualizing the dynamic processes of liquid-liquid phase separation and co-condensation. By labeling αSyn with AF647 (red) and Aβ variants with AF488 (green), they could track the formation, growth, and coalescence of condensates over time.
  • Thioflavin T (ThT) Fluorescence Assay: ThT is a dye that specifically binds to β-sheet structures characteristic of amyloid fibrils. By monitoring ThT fluorescence intensity over time, the researchers could quantify the rate of protein aggregation within the condensates, distinguishing between the liquid and solid states.
  • Kinetic Analysis: Time-lapse microscopy data was analyzed to extract kinetic parameters, such as the half-time of aggregation, allowing for quantitative comparisons of how different Aβ variants affected the speed of αSyn aggregation.
  • CamSol Solubility Scores: These were used to predict the intrinsic solubility of different Aβ variants, providing a theoretical basis for their observed aggregation behaviors.

Datasets

Not discussed in the paper. The study relies on in vitro experiments using purified proteins.

Key Insights and Ideas

  • Distinct Aβ Roles: The most striking finding is that Aβ42 and Aβ40 play fundamentally different roles in αSyn's phase behavior. This isn't just a matter of degree but a difference in mechanism.
  • Aβ42 as a Nucleator: Aβ42, known for its rapid aggregation, acts as a "seed" or nucleation site. It forms aggregates first, and these aggregates then provide a surface for αSyn to condense onto, initiating αSyn's phase separation.
  • Aβ40 as an Accelerator: In contrast, Aβ40, being more soluble, integrates into pre-formed αSyn condensates. Once inside, it accelerates the transition of these liquid condensates into solid amyloid aggregates.
  • Kinetic Diversity of Aβ Variants: The study demonstrates that not all Aβ variants behave the same. Shorter variants (Aβ37, Aβ39, Aβ35-25) mimic Aβ40's behavior (recruitment and acceleration), while longer variants (Aβ43) mimic Aβ42's behavior (forming aggregates and nucleating αSyn condensation). This highlights the sensitivity of these interactions to subtle changes in protein sequence.
  • Solubility Dictates Mechanism: The observed differences in Aβ variant behavior correlate well with their predicted intrinsic solubility, suggesting that a variant's propensity to aggregate independently dictates its role in the αSyn cocondensation process.

Key Results

  • Aβ42 aggregates were observed to directly nucleate αSyn liquid-liquid phase separation, acting as anchor points for condensate formation.
  • Aβ40 was found to be recruited into αSyn condensates, and its presence accelerated the liquid-to-solid transition of these condensates.
  • Kinetic analysis showed that higher concentrations of Aβ40 led to a faster aggregation of αSyn condensates, with a reduced half-time of aggregation.
  • Aβ43 exhibited a nucleation mechanism similar to Aβ42, while Aβ37, Aβ39, and Aβ35-25 showed behavior similar to Aβ40.
  • When Aβ and αSyn were mixed at equimolar concentrations (100 µM each), Aβ aggregated almost instantaneously, sequestering αSyn monomers and preventing liquid condensate formation, leading to direct co-aggregation.

Limitations and Future Work

  • In Vitro System: The study is conducted in vitro using purified proteins. While this allows for precise control and mechanistic dissection, it doesn't fully replicate the complex cellular environment with its myriad of other molecules and cellular machinery.
  • Specific Aβ Variants: While several Aβ variants were tested, the full spectrum of naturally occurring or disease-associated Aβ modifications was not explored.
  • Cellular Relevance: Future work could focus on validating these findings in cellular models to understand how these in vitro mechanisms translate to biological systems.
  • Therapeutic Targeting: The authors suggest that understanding these distinct kinetic pathways opens avenues for developing targeted therapeutics that could specifically disrupt the detrimental co-aggregation of Aβ and αSyn. Investigating how small molecules or antibodies might interfere with these specific interactions is a promising direction.

Summary updated

Abstract

The aggregation of amyloid-β (Aβ) and α-synuclein (αSyn) into insoluble proteinaceous deposits is a hallmark of Alzheimer's and Parkinson's diseases. Recent evidence suggests that these amyloidogenic proteins act in synergy, with their coaggregation frequently observed in these disorders. In this study, we investigate the interaction of Aβ and αSyn using various biophysical tools. In particular, we explore the cocondensation of Aβ with αSyn, elucidating the pathways through which Aβ modulates αSyn phase separation. We studied different variants of Aβ, focusing on the most prominent species, namely Aβ42 and Aβ40. We found that Aβ42 and Aβ40 have fundamentally different mechanistic effects on the kinetics of αSyn condensation. Aβ42 initially forms large aggregates that act as heterogeneous nucleation sites which initiate the phase separation of αSyn. In contrast, Aβ40 is sequestered into αSyn condensates where it accelerates the liquid-to-solid transition of αSyn into amyloid aggregates. All other Aβ variants we probed fell into one of these two mechanistic pathways, with Aβ37, Aβ39, and Aβ35-25 exhibiting similar behavior to Aβ40, whereas Aβ43 triggered nucleation processes similar to Aβ42. Given the complexity behind amyloid formation, it is key to understand how molecular partners can interact with one another. Our results thus illustrate the extreme sensitivity of protein mixtures and shed light on some of the mechanisms involved in the cocondensation and aggregation of Aβ with αSyn.
BibTeX
@inproceedings{rontgen2025amyloid,
  author = {Alexander Röntgen and Zenon Toprakcioglu and Owen M. Morris and Michele Vendruscolo},
  title = {{Amyloid-β modulates the phase separation and aggregation of α-synuclein}},
  booktitle = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2501987122},
}
Figure